#BEGIN_DRUGCARD DB03178

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C10H12N5O6PS

# Chemical_IUPAC_Name:
9-[(2S,3aS,4S,6R,6aS)-2-hydroxy-6-(hydroxymethyl)-2-sulfanylidene-tetrahydro-2H-1,3,5,2$l^{5}-furo[3,4-d][1,3,2$l^{5}]dioxaphosphol-4-yl]-2-amino-6,9-dihydro-1H-purin-6-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Guanosine-2',3'-Cyclophosphorothioate

# HET_ID:
SGP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C10H12N5O6PS/c11-10-13-7-4(8(17)14-10)12-2-15(7)9-6-5(3(1-16)19-9)20-22(18,23)21-6/h2-3,5-6,9,16H,1H2,(H,18,23)(H3,11,13,14,17)/t3-,5+,6+,9+,22+/m1/s1

# InChI_Key:
InChIKey=QZEROIIFJLCOOE-PDBXSDAOSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3178

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
361.271

# Molecular_Weight_Mono:
361.024590343

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1GSP

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.87

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
2.38e+00 g/l

# Primary_Accession_No:
DB03178

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936594

# PubChem_Substance_ID:
46504776

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02899

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=C(N=CN2[C@H]2O[C@H](CO)[C@@H]3O[P@](O)(=S)O[C@H]23)C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:59 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rnaSA

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in RNA binding

# Drug_Target_1_General_References:
11455593	Laurents D, Perez-Canadillas JM, Santoro J, Rico M, Schell D, Pace CN, Bruix M: Solution structure and dynamics of ribonuclease Sa. Proteins. 2001 Aug 15;44(3):200-11.
1654932	Sevcik J, Dodson EJ, Dodson GG: Determination and restrained least-squares refinement of the structures of ribonuclease Sa and its complex with 3'-guanylic acid at 1.8 A resolution. Acta Crystallogr B. 1991 Apr 1;47 ( Pt 2):240-53.
3098582	Shlyapnikov SV, Both V, Kulikov VA, Dementiev AA, Sevcik J, Zelinka J: Amino acid sequence determination of guanyl-specific ribonuclease Sa from Streptomyces aureofaciens. FEBS Lett. 1986 Dec 15;209(2):335-9.
3118883	Shliapnikov SV, Both V, Kulikov VA, Dement'ev AA, Zelinka J: [Extracellular guanyl-specific ribonuclease Sa from the actinomycete Streptomyces aureofaciens. Primary structure and homology with ribonucleases from bacteria and fungi] Bioorg Khim. 1987 Jun;13(6):760-72.
8396032	Sevcik J, Zegers I, Wyns L, Dauter Z, Wilson KS: Complex of ribonuclease Sa with a cyclic nucleotide and a proposed model for the reaction intermediate. Eur J Biochem. 1993 Aug 15;216(1):301-5.
9757110	Sevcik J, Urbanikova L, Dauter Z, Wilson KS: Recognition of RNase Sa by the inhibitor barstar: structure of the complex at 1.7 A resolution. Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):954-63.
9819211	Hebert EJ, Giletto A, Sevcik J, Urbanikova L, Wilson KS, Dauter Z, Pace CN: Contribution of a conserved asparagine to the conformational stability of ribonucleases Sa, Ba, and T1. Biochemistry. 1998 Nov 17;37(46):16192-200.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2497

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
10576

# Drug_Target_1_Name:
Guanyl-specific ribonuclease Sa

# Drug_Target_1_Number_of_Residues:
96

# Drug_Target_1_PDB_ID:
1LNI

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00545	Ribonuclease

# Drug_Target_1_Protein_Sequence:
>Guanyl-specific ribonuclease Sa
DVSGTVCLSALPPEATDTLNLIASDGPFPYSQDGVVFQNRESVLPTQSYGYYHEYTVITP
GARTRGTRRIITGEATQEDYYTGDHYATFSLIDQTC

# Drug_Target_1_Reaction:
Two-stage endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in Gp with 2',3'-cyclic phosphate intermediates

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Two-stage endonucleolytic cleavage to nucleoside 3'-phosphates and 3'-phosphooligonucleotides ending in G-P with 2',3'-cyclic phosphate intermediates

# Drug_Target_1_SwissProt_ID:
P05798

# Drug_Target_1_SwissProt_Name:
RNSA_STRAU

# Drug_Target_1_Synonyms:
EC 3.1.27.3
RNase Sa

# Drug_Target_1_Theoretical_pI:
4.16

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03178
